Insulet Stock Return On Asset
| PODD Stock | USD 166.19 2.02 1.23% |
Insulet fundamentals help investors to digest information that contributes to Insulet's financial success or failures. It also enables traders to predict the movement of Insulet Stock. The fundamental analysis module provides a way to measure Insulet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insulet stock.
The current year's Return On Assets is expected to grow to 0.08. Insulet | Return On Asset |
Insulet Company Return On Asset Analysis
Insulet's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Insulet Return On Asset | 0.0609 |
Most of Insulet's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insulet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Insulet Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Insulet is extremely important. It helps to project a fair market value of Insulet Stock properly, considering its historical fundamentals such as Return On Asset. Since Insulet's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insulet's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insulet's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Insulet Total Assets
Total Assets |
|
Based on the latest financial disclosure, Insulet has a Return On Asset of 0.0609. This is 100.7% lower than that of the Health Care Equipment & Supplies sector and 100.34% lower than that of the Health Care industry. The return on asset for all United States stocks is 143.5% lower than that of the firm.
Insulet Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insulet's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insulet could also be used in its relative valuation, which is a method of valuing Insulet by comparing valuation metrics of similar companies.Insulet is currently under evaluation in return on asset category among related companies.
Insulet Fundamentals
| Return On Equity | 0.34 | ||||
| Return On Asset | 0.0609 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 12.37 B | ||||
| Shares Outstanding | 70.02 M | ||||
| Shares Owned By Insiders | 0.31 % | ||||
| Shares Owned By Institutions | 99.69 % | ||||
| Number Of Shares Shorted | 2.86 M | ||||
| Price To Book | 16.75 X | ||||
| Price To Sales | 7.23 X | ||||
| Revenue | 1.7 B | ||||
| Gross Profit | 805.6 M | ||||
| EBITDA | 220 M | ||||
| Net Income | 206.3 M | ||||
| Cash And Equivalents | 708.6 M | ||||
| Cash Per Share | 10.21 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.69 X | ||||
| Book Value Per Share | 10.48 X | ||||
| Cash Flow From Operations | 145.4 M | ||||
| Short Ratio | 3.75 X | ||||
| Earnings Per Share | 2.94 X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 236.83 | ||||
| Number Of Employees | 3 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 11.64 B | ||||
| Total Asset | 2.59 B | ||||
| Retained Earnings | (378 M) | ||||
| Working Capital | 1.13 B | ||||
| Current Asset | 190.76 M | ||||
| Current Liabilities | 65.16 M | ||||
| Net Asset | 2.59 B |
About Insulet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Insulet Piotroski F Score and Insulet Altman Z Score analysis. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.